# Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

> **NCT04855240** · PHASE2 · COMPLETED · sponsor: **ACADIA Pharmaceuticals Inc.** · enrollment: 239 (actual)

## Conditions studied

- Acute Postoperative Pain
- Bunionectomy

## Interventions

- **DRUG:** ACP-044 Dose A
- **DRUG:** ACP-044 Dose B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04855240
- **Lead sponsor:** ACADIA Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-29
- **Primary completion:** 2022-02-11
- **Final completion:** 2022-03-14
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04855240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04855240, "Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04855240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*